| 0.6483 -0.131 (-16.81%) | 10-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 1-year : | ||
| Resists | First : | Second : | ||
| Pivot price | ||||
| Supports | First : | Second : | ||
| MAs | MA(5) : | MA(20) : | ||
| MA(100) : | MA(250) : | |||
| MACD | MACD : | Signal : | ||
| %K %D | K(14,3) : | D(3) : | ||
| RSI | RSI(14): | |||
| 52-week | High : | Low : | ||
| If tomorrow: | Open lower | Open higher |
| High: | - | - |
| Low: | - | - |
| Close: | - | - |
Rite Aid Corporation, through its various subsidiaries, manages an extensive network of retail pharmacies across the United States. The company's business activities are structured into two main divisions: Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment focuses on dispensing prescription drugs and delivers a wide array of supplementary pharmacy and wellness services. These include administering key immunizations such as those for COVID-19, influenza, and shingles, along with providing assistance to customers managing conditions like hypertension, high cholesterol, and diabetes. It also offers advice on weight loss and quitting smoking, and educates patients on their medications and potential adverse effects. Beyond pharmaceutical care, this segment stocks a broad assortment of consumer goods, including over-the-counter medicines, personal care products, cosmetics, health and beauty aids, seasonal items, household essentials, food, beverages, greeting cards, general merchandise, and pet supplies, complemented by its own private brand line. Furthermore, it operates retail clinics and offers specialized healthcare coaching and disease management solutions to health plans and employers. In contrast, the Pharmacy Services segment provides a complete package of integrated pharmacy benefit management (PBM) offerings. These solutions comprise advanced technology systems, mail-order drug delivery, specialty pharmacy services for complex conditions, efficient network and rebate administration, claims processing, and various pharmacy discount initiatives. This segment is also responsible for managing prescription drug benefits under the federal Medicare Part D program and offering insurance plans to individuals and diverse institutional clients, such as health plans, commercial businesses, labor unions, and governmental entities at state and local levels. As of February 26, 2022, Rite Aid operated 2,450 retail pharmacy outlets spread across 17 states. Established in 1962, the corporation is headquartered in Philadelphia, Pennsylvania.
Fri, 10 Oct 2025
Rite Aid Seeks Urgent Court Approval to Sell Preference Claims Before Deadline Expires - chapter11cases.com
Mon, 06 May 2024
News | Rite Aid Acquires Brooks & Eckerd Pharmacy Chains - CoStar
Mon, 16 Oct 2023
Rite Aid Shareholders Are Wiped Out Under A Chapter 11 Bankruptcy Plan - Seeking Alpha
Thu, 20 Apr 2023
Rite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook - Business Wire
Fri, 03 Jun 2022
Rite Aid Corporation (RAD) Share Price Today | Rite Aid (RAD) Live NSE/BSE - valueresearchonline.com
Wed, 04 May 2022
Rite Aid's corporate closure plan claims two more area stores - bizjournals.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Outperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Outperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Pharmaceuticals
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | (%) |
| Held by Institutions | (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | |
| EPS Est Next Qtrly | |
| EPS Est This Year | |
| EPS Est Next Year | |
| Book Value (p.s.) | |
| Profit Margin | % |
| Operating Margin | % |
| Return on Assets (ttm) | % |
| Return on Equity (ttm) | % |
| Qtrly Rev. Growth | % |
| Gross Profit (p.s.) | |
| Sales Per Share | |
| EBITDA (p.s.) | |
| Qtrly Earnings Growth | % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | |
| PEG Ratio | |
| Price to Book value | |
| Price to Sales | |
| Price to Cash Flow |
| Dividend | |
| Forward Dividend | |
| Dividend Yield | 0% |
| Dividend Pay Date | |
| Ex-Dividend Date |
|
|
|
|
|
|
|
|
|